Elwood & Goetz Wealth Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$495K Sell
987
-36
-4% -$17.3K 0.07% 84
2026
Q1
$503K Sell
1,023
-8
-0.8% -$4.34K 0.09% 72
2025
Q4
$597K Buy
1,031
+18
+2% +$10.2K 0.11% 56
2025
Q3
$491K Buy
1,013
+38
+4% +$17.7K 0.09% 66
2025
Q2
$395K Buy
975
+63
+7% +$26.3K 0.09% 69
2025
Q1
$454K Buy
912
+75
+9% +$40.6K 0.11% 57
2024
Q4
$435K Sell
837
-30
-3% -$16.5K 0.11% 57
2024
Q3
$536K Buy
+867
New +$513K 0.13% 49

Other funds holding TMO

Elwood & Goetz Wealth Advisory Group's TMO Position: Q2 2026 in Review

Elwood & Goetz Wealth Advisory Group reduced its Thermo Fisher Scientific (TMO) stake by 3.5% in Q2 2026, selling an estimated $17.3K and leaving 987 shares worth $495K. The position accounts for 0.07% of the portfolio, ranked #84.

Elwood & Goetz Wealth Advisory Group first reported a position in TMO in Q3 2024 and has held it in 8 quarters since. The position peaked at $597K in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Elwood & Goetz Wealth Advisory Group held 987 shares of Thermo Fisher Scientific worth $495K as of Q2 2026.
  • Elwood & Goetz Wealth Advisory Group sold 36 Thermo Fisher Scientific shares in Q2 2026, an estimated $17.3K.
  • Thermo Fisher Scientific made up 0.07% of Elwood & Goetz Wealth Advisory Group's portfolio in Q2 2026, its #84 holding.
  • Elwood & Goetz Wealth Advisory Group first reported a position in Thermo Fisher Scientific in Q3 2024 and has held it in 8 quarters since.
  • Elwood & Goetz Wealth Advisory Group's Thermo Fisher Scientific position peaked at $597K in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Elwood & Goetz Wealth Advisory Group's 13F filing for Q2 2026, filed 13 Aug 2026.